RJF.MC
Laboratorio Reig Jofre SA
Price:  
2.99 
EUR
Volume:  
29,567.00
Spain | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RJF.MC WACC - Weighted Average Cost of Capital

The WACC of Laboratorio Reig Jofre SA (RJF.MC) is 7.9%.

The Cost of Equity of Laboratorio Reig Jofre SA (RJF.MC) is 8.60%.
The Cost of Debt of Laboratorio Reig Jofre SA (RJF.MC) is 5.50%.

Range Selected
Cost of equity 6.80% - 10.40% 8.60%
Tax rate 11.10% - 11.60% 11.35%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.2% - 9.6% 7.9%
WACC

RJF.MC WACC calculation

Category Low High
Long-term bond rate 3.1% 3.6%
Equity market risk premium 7.4% 8.4%
Adjusted beta 0.5 0.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 10.40%
Tax rate 11.10% 11.60%
Debt/Equity ratio 0.24 0.24
Cost of debt 4.00% 7.00%
After-tax WACC 6.2% 9.6%
Selected WACC 7.9%

RJF.MC's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for RJF.MC:

cost_of_equity (8.60%) = risk_free_rate (3.35%) + equity_risk_premium (7.90%) * adjusted_beta (0.5) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.